Drug interactions in the hematopoietic stem cell transplant (HSCT) recipient: what every transplanter needs to know, Bone Marrow Transplant, vol.33, pp.137-52, 2004. ,
, J Oncol Pharm Pract
Prevalence of potential drug-drug interactions in bone marrow transplant patients, Int J Clin Pharm, vol.33, pp.1002-1009, 2011. ,
Potential drug-drug interactions at a referral hematology-oncology ward in Iran: a cross-sectional study, Cancer Chemother Pharmacol, vol.71, pp.1619-1646, 2013. ,
Pattern and associated factors of potential drug-drug interactions in both pre-and early post-hematopoietic stem cell transplantation stages at a, 2014. ,
, Ann Hematol, vol.93, pp.1913-1935
Potential Interactions of Medication Prescribed in Discharge Letters from a Clinic for Hematology and Oncology, 2018. ,
, Oncol Res Treat, vol.41, pp.200-205
Prevalence and clinical significance of potential drug-drug interaction in hematopoietic stem cell transplantation, Cancer Chemother Pharmacol, vol.75, pp.393-400, 2015. ,
Complications of allogeneic hematopoietic stem cell transplantation, Cancer Invest, vol.32, pp.349-62, 2014. ,
Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study, Glomerular Filtration Rate and Impact on Long-Term Survival among Adults after Hematopoietic Cell Transplantation: A Prospective Cohort Study, vol.41, 2015. ,
, Clin J Am Soc Nephrol, 2018.
A new equation to estimate glomerular filtration rate, 2009. ,
, Ann Intern Med, vol.150, pp.604-616
Clinical Practice Guidelines For Chronic Kidney Disease: Evaluation, Classification and Stratification National Kidney Foundation, Kidney Disease Outcomes Quality Initiative, vol.55, pp.132-138, 2002. ,
Analysis of potential drug-drug interactions in medical intensive care unit patients, Pharmacotherapy, vol.34, pp.213-222, 2014. ,
Drug-drug interactions in the intensive care unit: Do they really matter?, J Crit Care, vol.38, pp.97-103, 2017. ,
Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors, Nephrol Dial Transplant, vol.25, pp.278-82, 2010. ,
Acute kidney injury in hematopoietic cell transplantation, Semin Nephrol, vol.30, pp.615-641, 2010. ,
, Biomarkers of Renal Function: Towards Clinical Actionability, 2017.
, Clin Pharmacol Ther, vol.102, pp.481-492
Acute kidney injury-epidemiology, outcomes and economics, Nat Rev Nephrol, vol.10, pp.193-207, 2014. ,
The 6R's of drug induced nephrotoxicity, BMC Nephrol, vol.18, p.124, 2017. ,
Food and Drug Administration. Drug Development and Drug Interactions: Table of Substrates ,